Alzheimer's Disease and Other Dementing Disorders
暂无分享,去创建一个
[1] C. Merril,et al. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. , 1986, The New England journal of medicine.
[2] R. Knight,et al. SEVERE PARKINSONISM IN TWO AIDS PATIENTS TAKING PROCHLORPERAZINE , 1987, The Lancet.
[3] M. Raskind,et al. Dementia and antipsychotic drugs. , 1987, Journal of Clinical Psychiatry.
[4] B. Navia,et al. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. , 1987, Archives of neurology.
[5] L. Teri,et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. , 1989, The American journal of psychiatry.
[6] F. Gage,et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor , 1987, Nature.
[7] R. Mayeux,et al. Clinical and biochemical features of depression in Parkinson's disease. , 1986, The American journal of psychiatry.
[8] J. Marshall,et al. Multi-infarct dementia , 1979, Journal of the Neurological Sciences.
[9] V. Hachinski,et al. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.
[10] R. S. Williams,et al. A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.
[11] J. Lindesay,et al. ALUMINIUM AND ALZHEIMER'S DISEASE , 1989, The Lancet.
[12] L. Teri,et al. Functional Status and Cognitive Impairment in Alzheimer's Patients With and Without Depression , 1989, Journal of the American Geriatrics Society.
[13] Cerebral atrophy in Parkinson syndrome. , 1982, Experimental brain research.
[14] L. Thal,et al. Choline chloride fails to improve cognition in Alzheimer's disease , 1981, Neurobiology of Aging.
[15] G. Zubenko. Progression of illness in the differential diagnosis of primary dementia. , 1990, The American journal of psychiatry.
[16] C. Nemeroff,et al. Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Folstein,et al. Familial Alzheimer Dementia: a prevalent disorder with specific clinical features , 1984, Psychological Medicine.
[18] D. Crapper,et al. Brain Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary Degeneration , 1973, Science.
[19] L. Heston,et al. Pick's disease. Clinical genetics and natural history. , 1987 .
[20] E. Perry,et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[21] L. Hurst,et al. Unnecessary Use of Tranquillizers in Elderly Patients , 1966, British Journal of Psychiatry.
[22] J. Meyer,et al. Lecithin and memory training in suspected Alzheimer's disease. , 1982, Journal of Gerontology.
[23] S. Borson,et al. Neuroendocrine responses to physostigmine in Alzheimer's disease. , 1989, Archives of general psychiatry.
[24] J. de Figueiredo,et al. Transmission studies from blood of Alzheimer disease patients and healthy relatives. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Mansell,et al. Cognitive impairment due to AIDS-related complex and its response to psychostimulants. , 1988, Psychosomatics.
[26] Dementia of the Alzheimer type , 1987, Neurology.
[27] R. Maclennan,et al. DIETARY FIBRE, TRANSIT-TIME, FÆCAL BACTERIA, STEROIDS, AND COLON CANCER IN TWO SCANDINAVIAN POPULATIONS Report from the International Agency for Research on Cancer Intestinal Microecology Group , 1977, The Lancet.
[28] R. Janssen,et al. Human immunodeficiency virus (HIV) infection and the nervous system , 1989, Neurology.
[29] L. Lipkin,et al. DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION , 1961, Journal of neuropathology and experimental neurology.
[30] R. Mayeux,et al. The relationship of serotonin to depression in Parkinson's disease , 1988, Movement disorders : official journal of the Movement Disorder Society.
[31] L. Pt,et al. Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. , 1982 .
[32] S. M. Sumi,et al. Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. , 1988, Science.
[33] R. Sulkava. Alzheimer's disease and senile dementia of Alzheimer type , 1982 .
[34] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[35] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[36] P. Colletti,et al. Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. , 1988, The American journal of psychiatry.
[37] A. Schmaier,et al. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. , 1990, Science.
[38] L M Schuman,et al. Head injury as a risk factor for Alzheimer's disease , 1985, Neurology.
[39] J. Beyer,et al. Familial risk of dementia associated with a biologic subtype of Alzheimer's disease. , 1988, Archives of general psychiatry.
[40] R. Jope,et al. Biological and Neuropsychological Characterization of Physostigmine Responders and Nonresponders in Alzheimer's Disease , 1990, Journal of the American Geriatrics Society.
[41] M. Raskind,et al. TSH responses to two TRH doses in men with alzheimer's disease , 1988, Psychoneuroendocrinology.
[42] J. Trojanowski,et al. Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. , 1988, AJR. American journal of roentgenology.
[43] P. Whybrow,et al. Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. , 1969, Archives of general psychiatry.
[44] S. E. Børgesen,et al. Prognosis of dementia in normal‐pressure hydrocephalus after a shunt operation , 1986, Annals of neurology.
[45] R. Levi‐montalcini,et al. The nerve growth factor 35 years later. , 1987, Science.
[46] B. Turetsky,et al. Preservation of normal cognitive functioning in elderly subjects with extensive white-matter lesions of long duration. , 1990, Archives of General Psychiatry.
[47] U. Roessmann,et al. Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations , 1980, Annals of neurology.
[48] J. Sidtis,et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.
[49] R. Chaisson,et al. Survival patterns of the first 500 patients with AIDS in San Francisco. , 1988, The Journal of infectious diseases.
[50] S. Gauthier,et al. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. , 1990, The New England journal of medicine.
[51] M. Kuskowski,et al. Gender differences in TRH-stimulated TSH and prolactin in primary degenerative dementia and elderly controls , 1990, Biological Psychiatry.
[52] G. Pearlson,et al. Association between family history of affective disorder and the depressive syndrome of Alzheimer's disease. , 1990, American Journal of Psychiatry.
[53] R. Godwin-Austen,et al. DIFFUSE LEWY BODY DISEASE: AN IMPORTANT DIFFERENTIAL DIAGNOSIS IN DEMENTIA WITH EXTRAPYRAMIDAL FEATURES , 1989, Progress in clinical and biological research.
[54] N. Lassen,et al. Multi-infarct dementia. A cause of mental deterioration in the elderly. , 1974, Lancet.
[55] D. Nutt,et al. A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism , 1990, Acta psychiatrica Scandinavica.
[56] S. Larson,et al. RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINE , 1987, The Lancet.
[57] S. Gershon,et al. Dementia, Depression, and Pseudodementia , 1987 .
[58] S. M. Sumi,et al. Parkinson's disease in patients with Alzheimer's disease. , 1986, Archives of neurology.
[59] R Harrop,et al. Positron emission tomography and histopathology in Pick's disease , 1987, Neurology.
[60] J. Ferguson,et al. Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia , 1981, British Journal of Psychiatry.
[61] R. Katzman.,et al. Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.
[62] T. De,et al. Parenteral nutrition before gastrointestinal surgery. , 1982 .
[63] J. Blass,et al. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. , 1977, The New England journal of medicine.
[64] M. Leon,et al. Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. , 1986, AJNR. American journal of neuroradiology.
[65] R. Cawley. MENTAL HEALTH: It's Healthy to be Human. , 1968, British Journal of Psychiatry.
[66] P. Yates,et al. The noradrenergic system in Alzheimer and multi-infarct dementias. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[67] M. Beal,et al. Somatostatin: alterations in the central nervous system in neurological diseases. , 1986, Research publications - Association for Research in Nervous and Mental Disease.
[68] Robert H. Perry,et al. Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.
[69] L. Forno. Pathology of Parkinson's disease , 1981 .
[70] F. Gage,et al. Potential use of nerve growth factor to treat Alzheimer's disease , 1989, Neurobiology of Aging.
[71] F. Gage,et al. Morphological response of axotomized septal neurons to nerve growth factor , 1988, The Journal of comparative neurology.
[72] R. G. Wieland. Vitamin B12 Deficiency in the Nonanemic Elderly , 1986, Journal of the American Geriatrics Society.
[73] S H Ferris,et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. , 1987, The Journal of clinical psychiatry.
[74] N. Kendig,et al. The implications of the acquired immunodeficiency syndrome for gerontology research and geriatric medicine. , 1990, Journal of gerontology.
[75] J. Fleiss,et al. Clinical implications of imipramine plasma levels for depressive illness. , 1977, Archives of general psychiatry.
[76] J. Ritchie,et al. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. , 1982, The New England journal of medicine.
[77] J. Yesavage,et al. Thyrotropin-releasing hormone stimulation test and alzheimer's disease , 1986, Biological Psychiatry.
[78] D. Pollen,et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.
[79] P. S. St George-Hyslop,et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.
[80] D. Neary,et al. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. , 1985, The New England journal of medicine.
[81] D. Perl,et al. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. , 1980, Science.
[82] R. L. Rogers,et al. Improved cognition after control of risk factors for multi-infarct dementia. , 1986, JAMA.
[83] L. Thal,et al. Oral physostigmine and lecithin improve memory in Alzheimer disease , 1983, Annals of neurology.
[84] L. Villa-komaroff,et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.
[85] G. Långström,et al. Dexamethasone Suppression Test and Serum Prolactin in Dementia Disorders , 1983, British Journal of Psychiatry.
[86] A. Kling,et al. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.
[87] L. Resnick,et al. Early penetration of the blood‐brain‐barrier by HIV , 1988, Neurology.
[88] J. M. Vance,et al. Genetic linkage studies in Alzheimer's disease families , 1988, Experimental Neurology.
[89] W. A. Lishman. Cerebral disorder in alcoholism: syndromes of impairment. , 1981, Brain : a journal of neurology.
[90] M. Yoshimura,et al. Lewy body disease with and without dementia: a clinicopathological study of 35 cases. , 1988, Clinical neuropathology.
[91] Y. Agid,et al. Somatostatin and dementia in Parkinson's disease , 1983, Brain Research.
[92] J. Pearce. The extrapyramidal disorder of Alzheimer's disease. , 1974, European Neurology.
[93] W. Breitbart,et al. AIDS AND NEUROLEPTIC MALIGNANT SYNDROME , 1988, The Lancet.
[94] R. Godwin-Austen,et al. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[95] R. Mayeux,et al. Long‐term administration of oral physostigmine in Alzheimer's disease , 1988, Neurology.
[96] B. Navia,et al. The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.
[97] J. Brody,et al. Prognosis of general paresis after treatment. , 1968, Lancet.
[98] M. Forsling,et al. Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases. , 1983, Journal of neurology, neurosurgery, and psychiatry.
[99] L Ketonen,et al. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? , 1987, Journal of neurology, neurosurgery, and psychiatry.
[100] H. Kalmus,et al. Morbus Alzheimer and Morbus Pick. , 1953 .
[101] C. Wikkelsø,et al. The clinical effect of lumbar puncture in normal pressure hydrocephalus. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[102] H. Sackeim,et al. A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. , 1989, Archives of neurology.
[103] W. D. Ehmann,et al. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging , 1981, Annals of neurology.
[104] M. Roth,et al. Observations on the brains of non-demented old people. , 1968, Journal of the neurological sciences.
[105] M. Albert,et al. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial. , 1990, The Journal of clinical psychiatry.
[106] G. Román. The identity of lacunar dementia and Binswanger disease. , 1985, Medical hypotheses.
[107] S. Yen,et al. Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1. , 1988, The Journal of biological chemistry.
[108] C. Harper. Wernicke's encephalopathy: a more common disease than realised. A neuropathological study of 51 cases. , 1979, Journal of neurology, neurosurgery, and psychiatry.
[109] B. Reifler. Arguments for Abandoning the Term Pseudodementia , 1982, Journal of the American Geriatrics Society.
[110] G. Belle,et al. The association between aluminum-containing products and Alzheimer's disease. , 1990, Journal of clinical epidemiology.
[111] R. Strachan,et al. Psychiatric syndromes due to avitaminosis B 12 with normal blood and marrow. , 1965, The Quarterly journal of medicine.
[112] A. Coppen,et al. Dexamethasone Suppression Test in Dementia , 1987, Journal of The American Geriatrics Society.
[113] R. Gerner,et al. Does the dexamethasone suppression test distinguish dementia from depression? , 1982, The American journal of psychiatry.
[114] D. Selkoe,et al. Sharing of specific antigens by degenerating neurons in Pick's disease and Alzheimer's disease. , 1985, The New England journal of medicine.
[115] J. Coyle,et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.
[116] G. di Chiro,et al. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[117] S. Cajal,et al. Reduced lumbar CSF somatostatin levels in Alzheimer's disease. , 1982, Life sciences.
[118] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[119] C. Petito. Review of central nervous system pathology in human immunodeficiency virus infection , 1988, Annals of neurology.
[120] Martin Farrall,et al. PREDISPOSING LOCUS FOR ALZHEIMER'S DISEASE ON CHROMOSOME 21 , 1989, The Lancet.
[121] D. Price,et al. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease , 1986, Nature.
[122] R. Mayeux,et al. Heterogeneity in dementia of the Alzheimer type , 1985, Neurology.
[123] Hippocampal sympathetic ingrowth in rats and guinea pigs: quantitative morphometry and topographical differences , 1986, Brain Research.
[124] L. Heston,et al. Aluminum levels in brain in Alzheimer's disease. , 1978, Biological psychiatry.
[125] L. F. Kromer. Nerve growth factor treatment after brain injury prevents neuronal death. , 1987, Science.
[126] K. Marder,et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. , 1988, Archives of neurology.
[127] S. M. Sumi,et al. Myoclonus, Seizures, and Paratonia in Alzheimer Disease , 1990, Alzheimer disease and associated disorders.
[128] S. Perry,et al. Organic mental disorders caused by HIV: update on early diagnosis and treatment. , 1990, The American journal of psychiatry.
[129] R. Mayeux,et al. Coexisting dementia and depression in Parkinson's disease. , 1989, Archives of neurology.
[130] P. Tariot,et al. TRH stimulation test in dementia of the Alzheimer type and elderly controls , 1985, Psychiatry Research.
[131] E. Peskind,et al. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. , 1982, The American journal of psychiatry.
[132] E. Perry,et al. Cholinergic and Dopaminergic Activities in Senile Dementia of Lewy Body Type , 1990, Alzheimer disease and associated disorders.
[133] J. Cummings,et al. Kluver‐Bucy Syndrome in Pick disease , 1981, Neurology.
[134] J. Riley,et al. Morphological alterations in hippocampus after long-term alcohol consumption in mice. , 1978, Science.
[135] E. Larson,et al. Dementia in elderly outpatients: a prospective study. , 1984, Annals of internal medicine.
[136] P. Sørensen,et al. CSFandplasma vasopressmconcentrations in dementia , 1983 .
[137] C. Cotman,et al. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.
[138] A. Brun,et al. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.
[139] Memory complaints and impairment in normal, depressed, and demented elderly persons identified in a community survey. , 1990 .
[140] P. Rabins. Psychopathology of Parkinson's disease. , 1982, Comprehensive psychiatry.
[141] K. Davis,et al. Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. , 1987, Archives of general psychiatry.
[142] D. Dorsa,et al. Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin , 1986 .
[143] D. Selkoe,et al. Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease , 1986, Journal of neurochemistry.
[144] D. Nochlin,et al. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.
[145] S. Mirra,et al. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients , 1987, Neurology.
[146] Anterior pituitary response to thyrotrophin releasing hormone in senile dementia (Alzheimer type) and elderly normals , 1986, Acta psychiatrica Scandinavica.
[147] R. Katzman.,et al. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa , 1980, Nature.
[148] R. Prien,et al. Pharmacologic treatment of elderly patients with organic brain syndrome: a survey of twelve Veterans Administration Hospitals. , 1977, Comprehensive psychiatry.
[149] E. Perry,et al. Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. , 1990, JAMA.
[150] J. K. Levy,et al. Psychostimulant response in AIDS-related complex patients. , 1989, The Journal of clinical psychiatry.
[151] R. Mayer,et al. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[152] W. Edge. Typhoid fever treated with chloramphenicol; review of 16 cases. , 1950, Lancet.
[153] P. Davies,et al. Recent advances in the neurochemistry of Alzheimer's disease. , 1987, The Journal of clinical psychiatry.
[154] T. Halonen,et al. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[155] K. Davis,et al. Enhancement of memory by physostigmine. , 1979, The New England journal of medicine.
[156] E. Larson,et al. Coexistence of cognitive impairment and depression in geriatric outpatients. , 1982, The American journal of psychiatry.
[157] D. Neary,et al. Alzheimer's disease: a correlative study. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[158] M. Rechsteiner,et al. Ubiquitin-mediated pathways for intracellular proteolysis. , 1987, Annual review of cell biology.
[159] J. Brust. Vascular dementia‐‐still overdiagnosed. , 1983, Stroke.
[160] L. Libow,et al. Pernicious Anemia in the Demented Patient Without Anemia or Macrocytosis , 1986, Journal of the American Geriatrics Society.
[161] M. Raskind,et al. Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. , 1982, The American journal of psychiatry.
[162] D. Price,et al. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.
[163] R. Gherardi,et al. PATHOLOGY OF THE CENTRAL NERVOUS SYSTEM IN 40 CASES OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) , 1988, Neuropathology and applied neurobiology.
[164] L. Teri,et al. Dementia of the Alzheimer's Type and Depression , 1986, Journal of the American Geriatrics Society.
[165] D. Selkoe,et al. Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues. , 1990, Science.
[166] C. Salzman. Treatment of the elderly agitated patient. , 1987, The Journal of clinical psychiatry.
[167] W. Gibb,et al. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). , 1987, Brain : a journal of neurology.
[168] J. Growdon,et al. CSF vasopressin concentration is reduced in Alzheimer's disease , 1986, Neurology.
[169] J Marshall,et al. Cerebral blood flow in dementia. , 1975, Archives of neurology.
[170] J. Trojanowski,et al. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. , 1988, AJR. American journal of roentgenology.
[171] W E Wilkinson,et al. Alzheimer's disease: A study of epidemiological aspects , 1984, Annals of neurology.
[172] J. Dimsdale,et al. Extrapyramidal reactions. Neuropsychiatric mimics in patients with AIDS. , 1989, General hospital psychiatry.
[173] J. Mazziotta,et al. Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. , 1989, Archives of general psychiatry.
[174] L. Iversen,et al. Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes. , 1987, Archives of general psychiatry.
[175] Lipton Ra,et al. Letter: Factor VIII. , 1973, Lancet.
[176] E. Podell,et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. , 1988, The New England journal of medicine.
[177] E K Perry,et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.
[178] B. Truman,et al. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. , 1987, The New England journal of medicine.
[179] C. Marsden,et al. HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE? , 1984, The Lancet.
[180] G. Selzer. CHELATING AGENTS IN WILSON'S DISEASE. , 1963, Lancet.
[181] W. Wilson,et al. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation. , 1982, Journal of clinical psychopharmacology.
[182] K. Davis,et al. Oral physostigmine treatment of patients with Alzheimer's disease. , 1985, The American journal of psychiatry.
[183] C. Brewer,et al. Brain damage due to alcohol consumption: an air-encephalographic, psychometric and electroencephalographic study. , 1971, The British journal of addiction to alcohol and other drugs.
[184] G. Reynolds,et al. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations. , 1985, JAMA.
[185] L. Kurland,et al. A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease , 1987, Neurology.
[186] R. Sapolsky,et al. Stress and glucocorticoids in aging. , 1987, Endocrinology and metabolism clinics of North America.
[187] J. Constantinidis,et al. Pick’s Disease , 1974 .
[188] J. Woodard. CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY‐SEVEN CASES , 1962, Journal of neuropathology and experimental neurology.
[189] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[190] Z. J. Lipowski. Organic Mental Disorders , 1985 .
[191] D. Price,et al. Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy , 1987, Neurology.
[192] D. McLachlan,et al. Aluminum and alzheimer's disease , 1986, Neurobiology of Aging.
[193] T. Dawson,et al. Receptor alterations associated with serotonergic agents: an autoradiographic analysis. , 1987, The Journal of clinical psychiatry.
[194] K. Davis,et al. Antemortem markers of Alzheimer's disease , 1986, Neurobiology of Aging.
[195] D. Selkoe,et al. The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[196] J. Halter,et al. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. , 1984, Archives of general psychiatry.
[197] C. Finch,et al. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.
[198] D. Roberts,et al. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease. , 1984, Neurosurgery.
[199] E. Perry,et al. ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE , 1986, The Lancet.
[200] M. Ball. The Morphological Basis of Dementia in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[201] D. Price,et al. The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.
[202] R. D. Adams,et al. SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME. , 1965, The New England journal of medicine.
[203] A. Hakim,et al. Dementia in Parkinson disease , 1979, Neurology.
[204] P. Mölsä,et al. Extrapyramidal signs in Alzheimer's disease , 1984, Neurology.
[205] D. Selkoe,et al. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.
[206] B. Scatton,et al. Parkinson's disease and dementia , 1987, Neurology.
[207] R G Robinson,et al. Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.
[208] B T Hyman,et al. Alz‐50 Antibody recognizes alzheimer‐related neuronal changes , 1988, Annals of neurology.
[209] M. Norenberg,et al. Diffuse Lewy body disease and progressive dementia , 1988, Neurology.